Technion Seed
VC Fund
Haifa, Israel
Technion Seed is a seed-stage investment firm, owned jointly by four top-tier Venture Capital funds – Vertex Venture Capital, Battery Ventures (US-based), SCP-Vitalife and ProSeed – and the Technion Research & Development Foundation. Through Technion Seed, these funds invest in high market potential technological ideas and ventures, thatare still at an early stage and with very high uncertainty. The investment in such ventures – initially up to about $1,000,000 – is made both directly by the funds and indirectly through Technion Seed. The purpose of the initial investment is to enable the entrepreneurs to prove the viability of their idea. Success in the initial phase will then lead to a large round of financing by the funds, for continued growth of the venture. Technion Seed and its owners invest in a wide variety of areas, including communications, IT, internet, medical devices, renewable energy, new materials and more.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Technion Seed invests in
Stages Technion Seed invests in
Countries Technion Seed invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $800k–$4M
- Series A
- $750k–$12M
Investment Focus
Industry
- Medical 2 (25%)
- Health Care 2 (25%)
- Big Data 1 (13%)
- Printing 1 (13%)
- Security 1 (13%)
Stage
- Series A 4 (50%)
- Seed 3 (38%)
- Venture - Series Unknown 1 (13%)
Country
- Israel 7 (88%)
- United States 1 (13%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Dalia Mor
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
Moshe Katzenelson
General Manager
|
General Manager | Total investments: 0 | Find email | |
Nitza Kardish
VP Business Development
|
VP Business Development | Total investments: 8 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| VineSight uses content-agnostic AI to identify suspicious share patterns whether it’s spread by tweets, posts, deepfakes, videos, or memes. With VineSight customized solutions, users can respond quickly to toxic attacks while maintaining control of their brand's story. VineSight's AI-powered technology provides precise, all-encompassingprotection across social media platforms and online forums, allowing for rapid mitigation of reputational threats. | $4M / Seed / Sep 15, 2022 | ||
| Aren is an AI-powered platform that empowers engineers and asset owners to assess and manage civil infrastructure while minimizing the risk of failure and optimizing budgets. Its technology offers a cost-effective, automated, and quantitative approach to de-risk the asset management practice using computer vision and machine learning. | $2.4M / Seed / Sep 20, 2021 | ||
| Envizion Medical is a medical device company that develops electromagnetic feeding tube placement devices.The device, the ENvue System aims to save time and improve patient safety. It uses multiple sensors and anatomical landmarks to generate an image to map each patient’s anatomy to their upper GI tract in order to trace the feeding tubeaccurately. This device enhances small bowel placements by providing vision at the bedside assuring accurate placement, quicker time to feeding, and shortened ICU stays.It was established in Tel Aviv, Tel Aviv in 2014. | $18M / Venture - Series Unknown / Sep 03, 2020 | ||
| Aleph Farms is an Israel-based food technology company designing new ways to grow quality animal products that improve sustainability, food security and animal welfare in our food systems. Founded in 2017, the company utilized cellular agriculture technology to unveil the world’s first cultivated thin-cut steak in 2018, the world’s first cultivatedribeye steak in 2021, and cultivated collagen in 2022. Under its product brand, Aleph Cuts, the company will launch its first product, the Petit Steak, grown from the non-modified cells of a premium Angus cow. For its contributions to climate leadership including a net zero commitment made in 2020, it has received top accolades from the World Economic Forum and the United Nations. | $12M / Series A / May 01, 2019 | ||
| DigiFlex offers a revolutionary inkjet CtP solution, transforming the quality of analog photopolymeric plates for the flexographic, letterpress, dry-offset and rotary silk screen printing technologies, to the digital era. -The first really affordable Computer-to-Plate solution for quality in-house plate making-Ideal for narrow webapplications printers-A great motivation to replace the traditional low quality film solution-The propriety, revolutionary, Bi-component ink is the result of years of research by top scientists and technologists with excellent printing industry track | $900K / Series A / Mar 31, 2008 | ||
| Vayar Vision turns images to knowledge: it's a Google for pictures and images, and a missing link between pixels and text.Transform your images into searchable ones. The visual tags are compatible with environments such as Flickr and Picasa. Vayar exposes hidden, beyond words, connections and associations between images. Vayar visualsearch results can be integrated with various decision support systems, and respond to the user with information, which is attached to the found images. When pixels communicate with words- the possibilities are endless. And you are invited to join the adventure. | Series A / Jan 31, 2008 | ||
APProtect
|
APProtect Ltd. provides anti-piracy protection solutions for consumer and business software developers and publishers. It offers Trusted Server Protection products to protect CAD tools and scientific applications in companies, universities, and other organizations; Online Software Protector family of products for protecting consumer software; andsplitting machine software, which operates on a binary and splits it into two parts. The company also provides splitting, site installation, and server hosting services. APProtect Ltd. was founded in 2004 and is based in Haifa, Israel. | $750K / Series A / Jul 27, 2006 | |
| GeneGrafts Ltd. is a biotechnology company developing proprietary technology for modulating excitable tissues, such as of brain or heart, by cell therapy. This new paradigm can be used for treatment of various diseases including Parkinson's disease and other neurological disorders or cardiac arrhythmias.They have developed a noveltechnology platform based on transplantation of cell grafts, isolated from the patient's own body, which defines the ion channels. These grafted cells integrate functionally and structurally with the target organ, and their electrical properties are derived from the expressed ion channels. The electrical properties of target organ are modulated in a predetermined way. This technology is designed for treatment of neurological disorders and cardiac arrhythmias. | $800K / Seed / Dec 17, 2003 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Technion Seed invest in?
Technion Seed invests primarily in Medical, Health Care and Big Data startups, most often at Series A and Seed stage. Most of the 8 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Technion Seed's check size?
Technion Seed typically joins rounds of $800k–$4M at Seed and $750k–$12M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Technion Seed participates in.
How do I contact Technion Seed?
Public channels for Technion Seed include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Technion Seed?
The team at Technion Seed includes Dalia Mor (Chief Financial Officer), Moshe Katzenelson (General Manager) and Nitza Kardish (VP Business Development). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
